$NBSE NeuBase Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NeuBase Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in NeuBase Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in NeuBase Therapeutics, Inc. for free.

CIK Number: 0001173281
IRS Number: 465622433
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NBSE
Company Address: 700 TECHNOLOGY DRIVE PITTSBURGH 15219
Phone number: 212-682-8452
Former name: PRIME RESOURCE INC, date of change: 2002-05-13
Former name: BBM HOLDINGS, INC., date of change: 2007-04-02
Former name: Ohr Pharmaceutical Inc, date of change: 2009-08-19

Market Capitalization: $48.55M
Prev close: $1.35
Average Daily Volume: 117,650
Days Low: $1.35
Year Low: $1.35
Year High: $4.05

NeuBase Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 13 2021NBSENeuBase Therapeuti ...McDougall Gerald JDirectorOption ExerciseA4.9192,219452,79592,219
Apr 27 2021NBSENeuBase Therapeuti ...RICHMAN ERIC IDirectorBuyP5.005,00025,00041,08036.1 K to 41.1 K (+13.86 %)
Apr 27 2021NBSENeuBase Therapeuti ...Stephan Dietrich APresident and CEOBuyP5.0012,00060,00024,52512.5 K to 24.5 K (+95.81 %)
Apr 27 2021NBSENeuBase Therapeuti ...GOLDSTEIN DOV A MDDirectorBuyP5.0012,00060,00022,00010 K to 22 K (+120.00 %)
Apr 27 2021NBSENeuBase Therapeuti ...Mann William RolandCOOBuyP5.005,00025,0005,0000 to 5 K
Dec 30 2020NBSENeuBase Therapeuti ...Stephan Dietrich APresident and CEOOption ExerciseA6.92164,9251,141,281164,925
Dec 30 2020NBSENeuBase Therapeuti ...Stephan Dietrich APresident and CEOGiftG0.001,273,82001,273,8192.5 M to 1.3 M (-50.00 %)
Dec 30 2020NBSENeuBase Therapeuti ...Stephan Dietrich APresident and CEOGiftG0.001,273,81902,547,6393.8 M to 2.5 M (-33.33 %)
Dec 30 2020NBSENeuBase Therapeuti ...Stephan Dietrich APresident and CEOGiftG0.001,273,81902,547,6393.8 M to 2.5 M (-33.33 %)
Dec 30 2020NBSENeuBase Therapeuti ...Stephan Dietrich APresident and CEOGiftG0.002,547,63902,547,6395.1 M to 2.5 M (-50.00 %)
Dec 30 2020NBSENeuBase Therapeuti ...Backenroth SamuelCFO, Treasurer & Se ...Option ExerciseA6.9241,915290,05241,915
Sep 11 2020OHRPNeuBase Therapeuti ...GOLDSTEIN DOV A MDDirectorOption ExerciseA8.8014,634128,77914,634
Sep 11 2020OHRPNeuBase Therapeuti ...Miralles Gines DiegoDirectorOption ExerciseA8.8014,634128,77914,634
Sep 11 2020OHRPNeuBase Therapeuti ...RICHMAN ERIC IDirectorOption ExerciseA8.8014,634128,77914,634
Sep 11 2020OHRPNeuBase Therapeuti ...PRENDERGAST FRANKLYN GDirectorOption ExerciseA8.8014,634128,77914,634

View all NeuBase Therapeutics, Inc. insider transactions.

Are IPOs Interesting for Small Investors?

Initial Public Offering is the first sale of stock by a privately owned company to the public. Companies negotiate a sale of their stock to an investment banker or several bankers that act as an underwriter for the offering. More ...

What Is a Rule 10b5-1 Plan?

Rule 10b5 is one of the most important acts put forth by the SEC. It prohibits fraud, misrepresentation, and deceit in the sale and purchase of securities on national exchanges. More ...

What Happens When a Company Gets Delisted?

When listed on a major exchange, such as the NYSE or Nasdaq, the companies and their stock have to meet several listing requirements on stock price, trading volume, capitalization, disclosure of material information or financial reporting. More ...

Contact us | Follow us on Twitter